Evidence map›Paper›PMID 42491279›Full record

ArticleFrontiers in oncology2026

Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker.

Huan Zhao, Chunlei Zheng, Yizhe Wang, Kezuo Hou, Xianghong Yang, Yang Cheng, Xiaofang Che, Shilin Xie, Shuo Wang, Tieqiong Zhang and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Huan ZhaoDepartment of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.
Chunlei ZhengDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Yizhe WangDepartment of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.
Kezuo HouDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xianghong YangDepartment of Pathology, Shengjing Hospital of China Medical University, Shenyang, China.
Yang ChengDepartment of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.
Xiaofang CheDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Shilin XieDepartment of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.
Shuo WangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Tieqiong ZhangDepartment of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.
Jian KangDepartment of Pulmonary Medicine, The First Hospital of China Medical University, Shenyang, China.
Yunpeng LiuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Dianzhu PanDepartment of Respiratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Xiujuan QuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xuejun HuDepartment of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.
Yibo FanDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.00181.].

Indexed as

biomarkerCBLBlung adenocarcinomamiR-1323prognosis

Identifiers

PMID42491279
PMCPMC13377224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.